Literature DB >> 17266063

Epidemiology and clinical course of Behçet's disease in the Reggio Emilia area of Northern Italy: a seventeen-year population-based study.

Carlo Salvarani1, Nicolò Pipitone, Maria Grazia Catanoso, Luca Cimino, Bruno Tumiati, Pierluigi Macchioni, Gianluigi Bajocchi, Ignazio Olivieri, Luigi Boiardi.   

Abstract

OBJECTIVE: To investigate the epidemiology and clinical course of Behçet's disease (BD) over a 17-year period in a defined area of northern Italy.
METHODS: All patients with incident BD diagnosed over a 17-year period (from January 1, 1988 to December 31, 2004) living in the Reggio Emilia area were identified through the following sources: physicians at Reggio Emilia Hospital, medical practitioners, and community-based specialists. We identified all patients registered in a centralized index and in the Reggio Emilia district database for rare diseases. Patients were followed up from the time of diagnosis until either their death or April 1, 2005.
RESULTS: Eighteen patients (9 men and 9 women) had complete BD. Mean +/- SD age at diagnosis was 33 +/- 7 years. The incidence rate of BD was 0.24 per 100,000. The prevalence of BD on January 1, 2005 was 3.8 per 100,000. No patients died during the followup period. Although all patients developed oral ulceration during the disease course, 22.2% had no oral lesions at disease onset. Eye disease occurred in 55.6%. Ocular disease was more common in men and appeared at disease onset or within the first few years of disease onset (median 3 years). Only 1 patient had loss of useful vision in at least 1 eye at the end of followup. In all affected patients, visual acuity improved once treatment was started.
CONCLUSION: This population-based study is the first to report the prevalence and incidence of BD in Italy. In Italian patients, BD is nonfatal and the prognosis of eye disease is good.

Entities:  

Mesh:

Year:  2007        PMID: 17266063     DOI: 10.1002/art.22500

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  24 in total

Review 1.  Behçet syndrome: is it one condition?

Authors:  H Yazici; S Ugurlu; E Seyahi
Journal:  Clin Rev Allergy Immunol       Date:  2012-12       Impact factor: 8.667

2.  Prevalence of Behcet's disease among adult patients consulting three major clinics in a Druze town in Israel.

Authors:  Pinchas Klein; Abraham Weinberger; Vered Jean Altmann; Salim Halabi; Saeed Fachereldeen; Ilan Krause
Journal:  Clin Rheumatol       Date:  2010-05-14       Impact factor: 2.980

Review 3.  Prevalence of Skin and Skin-Related Diseases in the Rochester Epidemiology Project and a Comparison with Other Published Prevalence Studies.

Authors:  Louise K Andersen; Mark D P Davis
Journal:  Dermatology       Date:  2016-03-25       Impact factor: 5.366

4.  Interleukin (IL)-1 inhibition with anakinra and canakinumab in Behçet's disease-related uveitis: a multicenter retrospective observational study.

Authors:  Claudia Fabiani; Antonio Vitale; Giacomo Emmi; Giuseppe Lopalco; Lorenzo Vannozzi; Silvana Guerriero; Stefano Gentileschi; Daniela Bacherini; Rossella Franceschini; Bruno Frediani; Mauro Galeazzi; Florenzo Iannone; Gian Marco Tosi; Luca Cantarini
Journal:  Clin Rheumatol       Date:  2016-12-16       Impact factor: 2.980

5.  Efficacy and safety of adalimumab in Behçet's disease-related uveitis: a multicenter retrospective observational study.

Authors:  Claudia Fabiani; Antonio Vitale; Giacomo Emmi; Lorenzo Vannozzi; Giuseppe Lopalco; Silvana Guerriero; Ida Orlando; Rossella Franceschini; Daniela Bacherini; Luca Cimino; Alessandra Soriano; Bruno Frediani; Mauro Galeazzi; Florenzo Iannone; Gian Marco Tosi; Carlo Salvarani; Luca Cantarini
Journal:  Clin Rheumatol       Date:  2016-11-16       Impact factor: 2.980

Review 6.  Behçet syndrome: a contemporary view.

Authors:  Hasan Yazici; Emire Seyahi; Gulen Hatemi; Yusuf Yazici
Journal:  Nat Rev Rheumatol       Date:  2018-01-03       Impact factor: 20.543

Review 7.  Behçet Disease: An Update for Dermatologists.

Authors:  Erkan Alpsoy; Burcin Cansu Bozca; Asli Bilgic
Journal:  Am J Clin Dermatol       Date:  2021-06-01       Impact factor: 7.403

8.  Ocular inflammation in Behçet disease: incidence of ocular complications and of loss of visual acuity.

Authors:  R Oktay Kaçmaz; John H Kempen; Craig Newcomb; Sapna Gangaputra; Ebenezer Daniel; Grace A Levy-Clarke; Robert B Nussenblatt; James T Rosenbaum; Eric B Suhler; Jennifer E Thorne; Douglas A Jabs; C Stephen Foster
Journal:  Am J Ophthalmol       Date:  2008-08-16       Impact factor: 5.258

9.  Epidemiology and clinical characteristics of Behçet's disease in the US: a population-based study.

Authors:  Kenneth T Calamia; Floranne C Wilson; Murat Icen; Cynthia S Crowson; Sherine E Gabriel; Hilal Maradit Kremers
Journal:  Arthritis Rheum       Date:  2009-05-15

10.  Lack of association of two polymorphisms of IRF5 with Behcet's disease.

Authors:  Haijun Li; Peizeng Yang; Zhengxuan Jiang; Shengping Hou; Lin Xie
Journal:  Mol Vis       Date:  2009-10-07       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.